Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02694640 · ClinicalTrials.gov registry record · NA

Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors

A NA study, sponsored by University of South Carolina.

Completed
Registry status
NA
Development phase
161
Enrollment target

NCT02694640: Completed NA study, sponsored by University of South Carolina.

NCT02694640 is a NA study that has completed, run by University of South Carolina. The registered enrollment target is 161 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02694640, a NA study, has completed, sponsored by University of South Carolina.

COMPLETED
Registry status
NA
Development phase
161 participants
Enrollment target

Study Summary

Exercise adoption enhances well-being and recovery from breast cancer. Researchers trained American Cancer Society volunteers to provide exercise counseling to breast cancer survivors and the survivors increased their exercise in the short-term. This RCT examines the effects of three maintenance conditions on survivors' exercise participation at longer follow-ups. The cost-effectiveness of the three groups will be examined to guide implementation of this peer mentoring approach in community-based organizations.

Primary Outcome

Through interviewer - administered Seven Day Activity Recall

Interventions

  • BEHAVIORAL Reach Plus
  • BEHAVIORAL Reach Plus Phone
  • BEHAVIORAL Reach Plus Message

Trial Details

FieldValue
Enrollment Target 161 participants
Start Date 2016-01
Est. Completion 2020-03
Phase NA
University of South Carolina

157 total trials

What the finished NCT02694640 record still lists

NCT02694640 is an interventional study that assigns participants to a tested intervention. The registered 161 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (89% lower).

The record links to 0 conditions, and to 3 interventions - of which Reach Plus is the first listed.

NCT02694640 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02694640 about?

NCT02694640 is a clinical study titled "Peers Promoting Exercise Adoption and Maintenance Among Cancer Survivors". Exercise adoption enhances well-being and recovery from breast cancer. Researchers trained American Cancer Society volunteers to provide exercise counseling to breast cancer survivors and the survivors increased their exercise in the short-term. This RCT examines the effects of three maintenance con...

What is the current status of trial NCT02694640?

This trial is currently completed. It is a NA study. The enrollment target is 161 participants. The study started on 2016-01. Estimated completion is 2020-03.

What interventions are being tested in trial NCT02694640?

The interventions under investigation include: Reach Plus (BEHAVIORAL), Reach Plus Phone (BEHAVIORAL), Reach Plus Message (BEHAVIORAL).

Who is sponsoring clinical trial NCT02694640?

This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02694640's enrollment target sits among peer trials

161 628th of 2000 higher than 1,373 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT06391034 · 161 participants · Phase 2

    Magnetic Resonance (MR) Imaging With Hyperpolarized 13C-Pyruvate +/- 13C,15N-Urea in Patients With Prostate Cancer

  • NCT06546670 · 161 participants · Phase 1

    A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease

  • NCT06616766 · 161 participants · Phase 1

    A Phase 1/2, Open-label, Multicenter, FIH Study to Evaluate Safety, Tolerability, PK and Anti-tumor Activity of YH42946

  • NCT06752356 · 161 participants · Phase 3

    A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02694640, the US trial registry maintained by the National Library of Medicine. NCT02694640 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.